Caenorhabditis elegans

Experimental Therapeutics
Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs
Hassan E. Eldesouky, Abdelrahman Mayhoub, Tony R. Hazbun, Mohamed N. Seleem
Epidemiology and Surveillance
Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model
Irina Sánchez-Diener, Laura Zamorano, Carla López-Causapé, Gabriel Cabot, Xavier Mulet, Carmen Peña, Rosa del Campo, Rafael Cantón, Antonio Doménech-Sánchez, Luis Martínez-Martínez, Susana C. Arcos, Alfonso Navas, Antonio Oliver
Experimental Therapeutics
Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds
Elamparithi Jayamani, Nagendran Tharmalingam, Rajmohan Rajamuthiah, Jeffrey J. Coleman, Wooseong Kim, Ikechukwu Okoli, Ana M. Hernandez, Kiho Lee, Gerard J. Nau, Frederick M. Ausubel, Eleftherios Mylonakis
Clinical Therapeutics
Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa
Erik van Tilburg Bernardes, Laetitia Charron-Mazenod, David J. Reading, Shauna L. Reckseidler-Zenteno, Shawn Lewenza

Main menu